Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod

Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for their Omicron JN.1-adapted monovalent COVID-19 vaccine.The CHMP has recommended the approval of Comirnaty JN.1, the Omicron JN.1-adapted monovalent COVID-19 vaccine, for active immunization against the COVID-19 virus in individuals aged six months and above.The decision was based on the recommendation from the World Health ...